Skip to Main Content

Hello, everyone, and how are you today? We are just fine, thank you. A cool breeze is wafting across the Pharmalot campus and our official mascot is, thankfully, snoozing away in a nearby corner. As for us, we are going about our usual business — brewing a cup of stimulation and foraging for interesting and saucy items. On that note, here are a few tidbits to help you get going this morning. As always, we wish you luck on your journey and, of course, please do keep in touch. …

AstraZeneca (AZN) chief executive Pascal Soriot said the company should know before the end of the year whether its experimental vaccine would protect people from Covid-19, if allowed to resume trials which were paused this week, Reuters writes. The drug maker suspended the late-stage trials after an illness in a study subject in the U.K. The patient was reportedly suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.